China · Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 11.47 billion. The enterprise value is 9.78 billion.
| Market Cap | 11.47B |
| Enterprise Value | 9.78B |
Important Dates
The next estimated earnings date is Tuesday, March 10, 2026.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | Sep 19, 2025 |
Share Statistics
SHE:301087 has 203.20 million shares outstanding. The number of shares has increased by 0.58% in one year.
| Current Share Class | 203.20M |
| Shares Outstanding | 203.20M |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | -2.31% |
| Owned by Insiders (%) | 11.25% |
| Owned by Institutions (%) | 16.18% |
| Float | 83.13M |
Valuation Ratios
The trailing PE ratio is 35.95 and the forward PE ratio is 27.11.
| PE Ratio | 35.95 |
| Forward PE | 27.11 |
| PS Ratio | 3.66 |
| PB Ratio | 2.41 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | 18.10 |
| P/OCF Ratio | 14.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.14, with an EV/FCF ratio of 15.43.
| EV / Earnings | 30.57 |
| EV / Sales | 3.12 |
| EV / EBITDA | 20.14 |
| EV / EBIT | 31.40 |
| EV / FCF | 15.43 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.38 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 1.67 |
| Debt / FCF | 1.28 |
| Interest Coverage | 19.71 |
Financial Efficiency
Return on equity (ROE) is 6.74% and return on invested capital (ROIC) is 8.48%.
| Return on Equity (ROE) | 6.74% |
| Return on Assets (ROA) | 2.99% |
| Return on Invested Capital (ROIC) | 8.48% |
| Return on Capital Employed (ROCE) | 6.36% |
| Weighted Average Cost of Capital (WACC) | 8.98% |
| Revenue Per Employee | 614,252 |
| Profits Per Employee | 62,768 |
| Employee Count | 5,099 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, SHE:301087 has paid 61.31 million in taxes.
| Income Tax | 61.31M |
| Effective Tax Rate | 16.08% |
Stock Price Statistics
The stock price has increased by +63.77% in the last 52 weeks. The beta is 0.95, so SHE:301087's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +63.77% |
| 50-Day Moving Average | 47.45 |
| 200-Day Moving Average | 39.62 |
| Relative Strength Index (RSI) | 62.53 |
| Average Volume (20 Days) | 6,799,754 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 3.13 billion and earned 320.05 million in profits. Earnings per share was 1.57.
| Revenue | 3.13B |
| Gross Profit | 1.64B |
| Operating Income | 311.63M |
| Pretax Income | 381.22M |
| Net Income | 320.05M |
| EBITDA | 426.65M |
| EBIT | 311.63M |
| Earnings Per Share (EPS) | 1.57 |
Balance Sheet
The company has 2.54 billion in cash and 813.30 million in debt, with a net cash position of 1.72 billion or 8.48 per share.
| Cash & Cash Equivalents | 2.54B |
| Total Debt | 813.30M |
| Net Cash | 1.72B |
| Net Cash Per Share | 8.48 |
| Equity (Book Value) | 4.75B |
| Book Value Per Share | 23.20 |
| Working Capital | 2.26B |
Cash Flow
In the last 12 months, operating cash flow was 817.51 million and capital expenditures -183.61 million, giving a free cash flow of 633.90 million.
| Operating Cash Flow | 817.51M |
| Capital Expenditures | -183.61M |
| Free Cash Flow | 633.90M |
| FCF Per Share | 3.12 |
Margins
Gross margin is 52.33%, with operating and profit margins of 9.95% and 10.22%.
| Gross Margin | 52.33% |
| Operating Margin | 9.95% |
| Pretax Margin | 12.17% |
| Profit Margin | 10.22% |
| EBITDA Margin | 13.62% |
| EBIT Margin | 9.95% |
| FCF Margin | 20.24% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.19%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.19% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 153.51% |
| Buyback Yield | -0.58% |
| Shareholder Yield | 2.68% |
| Earnings Yield | 2.79% |
| FCF Yield | 5.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
SHE:301087 has an Altman Z-Score of 3.7 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.7 |
| Piotroski F-Score | 6 |